COVID-19和疫苗诱导的血栓形成
Babak Sharif-Kashani1,2, Shadi Shafaghi2, Farah Naghashzadeh2
1Tobacco Prevention and Control Research Center(TPCRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Tanaffos
|August 16, 2023
概括
COVID-19显著增加了静脉血栓栓塞 (VTE) 的风险. 虽然很少见,疫苗诱导的免疫血栓性血栓性缺血症 (VITT) 是一种严重的副作用,但疫苗接种的好处超过了风险.
科学领域:
- 医学 医学 医学 医学 医学
- 传染性疾病 传染性疾病
- 血液学 血液学 血液学
背景情况:
- COVID-19在全球造成了数百万人的死亡,并且与静脉和动脉血栓栓塞的风险显著增加有关.
- 静脉血栓栓塞 (VTE) 影响了大量住院的COVID-19患者,特别是那些在重症监护中的患者.
- 疫苗接种对于控制大流行病至关重要,尽管很少有疫苗诱导的免疫血栓性血栓性缺血症 (VITT) 的报道.
研究的目的:
- 强调疫苗接种在打击COVID-19大流行中的重要性.
- 专注于疫苗诱导的免疫血栓性血栓性缺血症 (VITT) 作为一种罕见但严重的副作用.
- 强调COVID-19疫苗接种的好处明显超过潜在风险.
主要方法:
- 对包括VTE在内的COVID-19并发症的当前文献的审查.
- 在COVID-19患者中分析报告的VTE病例和发病率.
- 评估疫苗安全数据,重点关注VITT.
主要成果:
- COVID-19与高发病率的VTE有关,特别是在重症患者中.
- 疫苗接种是控制流行病的主要策略.
- 发生VITT的情况很少见,接种疫苗的整体好处是巨大的.
结论:
- 疫苗接种仍然是对抗COVID-19的最关键措施.
- 接种COVID-19疫苗的好处远远超过了与VITT等罕见副作用相关的风险.
- 继续强调疫苗接种对于公共卫生和流行病减缓至关重要.
相关概念视频
01:30Venous Thrombosis I: Introduction
12
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
12
01:29Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
753
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
753
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:51Vaccinations
44.7K
Overview
44.7K
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
14
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
14